With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Add better swallowing function to the benefits of IMRT for head and neck cancers with this prospective randomized trial demonstrating a clinical benefit when mean dose to pharyngeal constrictors is limited. | Nutting, ASCO 2020